(Q44611976)

4 December 2017

title

Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis (English)

1 reference

4 December 2017

0 references

1 reference

P. Schiedermaier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

19 March 2024

L. Koch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

19 March 2024

B. Stoffel-Wagner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

19 March 2024

G. Layer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

19 March 2024

T. Sauerbruch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

19 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14535870

full work available at URL

19 March 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2036.2003.01682.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535870

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01682.x

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01682.x

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Alimentary Pharmacology & Therapeutics

19 March 2024

published in

1 reference

4 December 2017

volume

18

1 reference

4 December 2017

issue

8

1 reference

4 December 2017

page(s)

777-784

1 reference

Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Effect of the somatostatin analogue lanreotide on meal-stimulated portal blood flow in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01682.X

Short-term effects of propranolol on portal venous pressure

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics

19 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis

19 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler study

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension

19 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: a randomized, controlled trial.

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure

19 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Short- and long-term hemodynamic response to octreotide in portal hypertensive patients: a double-blind, controlled study.

19 March 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension

19 March 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study

19 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Postprandial vascular response in patients with cirrhosis. Short-term effects of propranolol administration.

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol

19 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Noninvasive hemodynamic measurements of superior mesenteric artery in the prediction of portal pressure response to propranolol

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment

19 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Circadian occurrence of variceal bleeding in patients with liver cirrhosis

19 March 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Diurnal pattern of variceal bleeding in cirrhotic patients

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis

19 March 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis

19 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01682.X

19 March 2024

Identifiers

1 reference

4 December 2017

1 reference